For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Trellis Bioscience, Inc.

USPTO Granted Patents = 28

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 168

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Lawrence M Kauvar (28 out of 82 patents)

Angeles Estelles (9 out of 10 patents)

Orit Foord (7 out of 78 patents)

4. Stefan Ryser (7 out of 7 patents)

5. Gizette Sperinde (6 out of 8 patents)

6. Ellen J Collarini (6 out of 9 patents)

7. Minha Park (5 out of 7 patents)

8. Stote Ellsworth (5 out of 5 patents)

9. William Usinger (5 out of 9 patents)

10. Krista Maureen McCutcheon (5 out of 14 patents)

11. Bo Chen (4 out of 6 patents)

12. Reyna J Simon (4 out of 11 patents)

13. Bruce Alan Keyt (4 out of 41 patents)

14. Ying-Ping Jiang (4 out of 9 patents)

15. Lauren Opremcak Bakaletz (4 out of 63 patents)

28 patents: Sort by Forward Citations

1. 12246063 - Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof (2025-03-11),

2. 12152068 - Binding moieties for biofilm remediation (2024-11-26),

3. 11773143 - Conformational epitopes in respiratory syncytial virus G protein central conserved region (2023-10-03),

4. 11725055 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2023-08-15),

5. 11248040 - Binding moieties for biofilm remediation (2022-02-15),

6. 11246928 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2022-02-15),

7. 11046764 - Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3 (2021-06-29),

8. 10858431 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2020-12-08),

9. 10676520 - Antibodies useful in passive influenza immunization (2020-06-09),

10. 10654915 - Antibodies useful in passive influenza immunization (2020-05-19),

11. 10639370 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2020-05-05),

12. 10570193 - Binding moieties for biofilm remediation (2020-02-25),

13. 10233234 - Binding moieties for biofilm remediation (2019-03-19),

14. 10030069 - High affinity human antibodies to human cytomegalovirus (CMV) gB protein (2018-07-24),

15. 9688744 - High affinity human antibodies to human cytomegalovirus (CMV) GB protein (2017-06-27),

Trellis Bioscience, Inc. is a biotechnology company specializing in the discovery and development of therapeutic antibodies. With a focus on innovative approaches to target diseases, Trellis leverages advanced antibody technology platforms to create novel treatments. The company's mission is to improve patients' lives by delivering safe and effective therapies that address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

28 Patents

#89 in Mountain View, CA

#2,765 in California

#11,595 in US

#22,553 in the World

Mountain View, CA, United States of America

Trellis Bioscience, Inc.

Forward Citations = 168

28 inventors:

Lawrence M Kauvar (28 out of 82 patents)

Angeles Estelles (9 out of 10 patents)

Orit Foord (7 out of 78 patents)

4. Stefan Ryser (7 out of 7 patents)

5. Gizette Sperinde (6 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…